RRC ID 43527
著者 Hanyu K, Iida T, Shiba H, Ohashi T, Eto Y, Yanaga K.
タイトル Immunogene therapy by adenovirus vector expressing CD40 ligand for metastatic liver cancer in rats.
ジャーナル Anticancer Res
Abstract BACKGROUND:We have explored a gene-therapeutic approach to stimulate antitumor immunity by adenoviral-mediated transfer of CD40 ligand (CD40L) to treat metastatic liver cancer in a rat model.
MATERIALS AND METHODS:Rat metastatic liver cancer cells were implanted into the back of rats bilaterally. When the larger tumor reached 8.0 mm in diameter, adenovirus vector-expressing mouse CD40L was injected intratumorally as treatment group (n=5), while LacZ was injected in the control group (n=5).
RESULTS:In the control group, the tumor gradually grew to be 20.7+/-1.6 (mean+/-SD) mm in intratumorally injected tumors and 21.8+/-3.7 mm in opposite tumors seven weeks after injection, respectively. In contrast, in the treatment group, the tumor was reduced to 3.6+/-8.2 mm and 3.7+/-8.2 mm. The tumor growth and survival rate were significantly different (p<0.001).
CONCLUSION:Adenovirus vector-mediated CD40L gene therapy is an effective therapeutic method for metastatic liver cancer.
巻・号 28(5A)
ページ 2785-9
公開日 2008-1-1
PMID 19035311
MeSH Adenoviridae / genetics Animals CD40 Ligand / biosynthesis CD40 Ligand / genetics* CD40 Ligand / immunology* Flow Cytometry Genetic Therapy / methods Genetic Vectors Immunogenetics / methods* Liver Neoplasms, Experimental / genetics Liver Neoplasms, Experimental / immunology* Liver Neoplasms, Experimental / secondary Liver Neoplasms, Experimental / therapy* Male Rats Rats, Inbred F344
IF 1.994
引用数 7
WOS 分野 ONCOLOGY
リソース情報
ヒト・動物細胞 RCN-9(RCB0511)